Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Clinical significance of 18F-FDG uptake by primary sites in patients with diffuse large B cell lymphoma in the head and neck: a pilot study.

Autor: Byun BH, Na II, Cheon GJ, Kang HJ, Kim KM, Lee SS, Ryoo BY, Choi CW, Lim SM, Yang SH, Byun, Byung Hyun, Na, Im Il, Cheon, Gi Jeong, Kang, Hye Jin, Kim, Kyeong Min, Lee, Seung-Sook, Ryoo, Baek-Yeol, Choi, Chang Woon, Lim, Sang Moo, Yang, Sung Hyun

Publikováno v: Annals of Nuclear Medicine; Oct2008, Vol. 22 Issue 8, p645-651, 7p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Australia’s Policy at the Threshold of the 21st Century

Autor: Rafał Kamiński

Polityka zagraniczna Australii, tradycyjnie zorientowana głównie na relacje z USA, uległa w ostatnich latach wielu zmianom. Ewolucja układu sił w globalnej polityce, odczuwalna najbardziej w regionie Azji Wschodniej, doprowadziła do dowartości

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::563ca3d67b8b6290527f5cbb93265dd4
https://hdl.handle.net/11089/23457

A Phase II Study of ¹³¹ I-rituximab for Patients With Relapsed or Refractory Marginal Zone Lymphoma.

Autor: Jang YJ; Division of Hematology and Oncology, Department of Internal Medicine, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul, Republic of Korea., Lim SM; Department of Nuclear Medicine, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul, Republic of Korea., Lee I; Department of Nuclear Medicine, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul, Republic of Korea., Byun BH; Department of Nuclear Medicine, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul, Republic of Korea., Lim I; Department of Nuclear Medicine, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul, Republic of Korea., Kim BI; Department of Nuclear Medicine, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul, Republic of Korea., Choi CW; Department of Nuclear Medicine, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul, Republic of Korea., Lee SS; Department of Pathology, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul, Republic of Korea., Yang SH; Division of Hematology and Oncology, Department of Internal Medicine, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul, Republic of Korea., Na II; Division of Hematology and Oncology, Department of Internal Medicine, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul, Republic of Korea., Lee HR; Division of Hematology and Oncology, Department of Internal Medicine, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul, Republic of Korea., Shin DY; Division of Hematology and Oncology, Department of Internal Medicine, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul, Republic of Korea.; Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea., Kang HJ; Division of Hematology and Oncology, Department of Internal Medicine, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul, Republic of Korea.

Publikováno v: Clinical Medicine Insights. Oncology [Clin Med Insights Oncol] 2023 Dec 11; Vol. 17, pp. 11795549231218082. Date of Electronic Publication: 2023 Dec 11 (Print Publication: 2023).